2012 Annual Meeting | Hallucinations in Parkinsons Disease

Date Thursday 03/21/13

Time 06:30 AM - 08:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jennifer G. Goldman, MD, MS, FAAN

Topic(s)

Learning Objectives Participants should be able to describe the range of psychotic phenomenon in PD; screen PD patients for these symptoms during clinic visits; identify factors associated with the pathogenesis and progression of PD psychosis; discuss the challenges of clinical trials for antipsychotic medications in PD; and incorporate evidence-based medicine recommendations and integrated treatment options in the management of PD psychosis.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Interactive

Program Evaluations

Event Timeline
06:30 AM - 07:00 AM		Phenomenology and Progression Glenn T. Stebbins, PhD
06:30 AM - 08:30 AM		Break
07:00 AM - 07:30 AM		Clues to Pathogenesis Susan Fox, MD, FAAN
07:30 AM - 08:00 AM		Management and Challenges Jennifer G. Goldman, MD, MS, FAAN
08:00 AM - 08:30 AM		Cases and Discussion Susan Fox, MD, FAAN, Jennifer G. Goldman, MD, MS, FAAN, Glenn T. Stebbins, PhD

Faculty Disclosures
Jennifer G. Goldman, MD, MS, FAAN	Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation Scientific Advisory Board. The institution of Dr. Goldman has received research support from Michael J. Fox Foundation. The institution of Dr. Goldman has received research support from Parkinson's Foundation.
Susan Fox, MD, FAAN	The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.

��ɫ��

��ɫ��